Clinical trial
Acute Effects of Hyperventilation, Post-Activation Performance Enhancement, and Combined Protocols on Anaerobic Capacity and Energy System Contributions
NCT07903714 is registered in ClinicalTrials.gov with Manisa Celal Bayar University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Effects of Hyperventilation, Post-Activation Performance Enhancement, and Combined Protocols on Anaerobic Capacity and Energy System Contributions
- Lead sponsor
- Manisa Celal Bayar University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 11, 2026
- Completion date
- February 26, 2026
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anaerobic performance, energy system contributions, hyperventilation, post activation potentiation
Arms
As registered; 4 arms.
-
Control Session
Baseline 30-s Wingate test without prior intervention.
-
Hyperventilation (HV) Session
30-s Wingate test preceded by voluntary hyperventilation.
-
PAPE Session
30-s Wingate test preceded by PAPE protocol.
-
PAPE+HV Session
30-s Wingate test preceded by combined PAPE and hyperventilation protocols.
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Relative Peak Power (RPP)
Evaluation of relative peak power during the 30-second Wingate anaerobic test
-
Relative Mean Power (RMP)
Evaluation of relative mean power during the 30-second Wingate anaerobic test.
-
Fatigue Index (FI)
Evaluation of fatigue index during the 30-second Wingate anaerobic test.
Lead sponsor's other trials
Manisa Celal Bayar University, most recent start first.
+71 more trials See the organization page
Similar trials
Same condition (Hyperventilation) and phase, most recent start first.
+17 more trials See the condition page